What we do
Vaccines Europe proactively represents and voices vaccine industry views on key issues of common interest being discussed at EU level, raising awareness about the value of vaccination, the innovation taking place and the contribution of the industry in Europe and worldwide.
evidence to support the decision-making process
Examples
- Pipeline review
- Improving the attractiveness of the vaccines industry in the European Union
- Vaccine market access pathways in the EU27 and the United Kingdom − analysis and recommendations for improvements
- Addressing vaccine supply challenges in Europe: Expert industry perspective and recommendation
policy positions to support strong immunisation policies
Examples
- Updated Vaccines Europe Position on Joint Procurement of Vaccines in Europe
- Recommendations to improve tendering practices of vaccines in EU Member States
- Enhancing vaccine market access How can we improve timely access to vaccines and strengthen immunisation systems across the EU?
- Prioritising Adult Immunisation Policy in Europe
to EU institution public & stakeholder consultations relevant for immunisation policies
Examples
and/or contribute to multi-stakeholder platforms which cover key issues related to the complexity of the vaccine ecosystem
with the whole vaccine community, to exchange on best practices, share knowledge and expertise
Examples
in public-private partnership initiatives to accelerate research and implementation of effective tools to protect the people against vaccine-preventable diseases
Examples
independent initiatives aiming at leveraging the value of vaccination
Example
Vaccines Europe’s 2024-2026 strategy is centered around 4 pillars and 1 enabler, spanning the entire vaccine value chain
